Introduction: The effects of sodium-glucose cotransporter 2 inhibitors (SGLT2I) and
dipeptidyl peptidase-4 inhibitors (DPP4I) on new-onset cognitive dysfunction in type 2 …

Introduction: Whether aspirin or other antiplatelet drugs can reduce mortality among patients
with coronavirus disease (COVID-19) remains controversial. Methods: We identified …

Hypertension, diabetes mellitus, and coronary artery disease are common comorbidities and
dangerous factors for infection and serious COVID-19. Polymorphisms in genes associated …

Acute lung injury (ALI) is an acute hypoxic respiratory insufficiency or failure caused by
various factors inside and outside the lungs. ALI is associated with high morbidity and a poor …

Recent studies have reported numerous predictors for adverse outcomes in COVID-19
disease. However, there have been few simple clinical risk scores available for prompt risk …

Introduction Patients with diabetes mellitus are risk of premature death. In this study, we
developed a machine learning-driven predictive risk model for all-cause mortality among …

Introduction The risk of new onset depression associated with sodium-glucose co-
transporter 2 inhibitor (SGLT2I) use in patients with type 2 diabetes mellitus (T2DM) remains …

Background Early evidence has shown that anticoagulant reduces the risk of thrombotic
events in those infected with COVID-19. However, evidence of the role of routinely …

Background The present study evaluated the association between blood pressure variability
and the risk of hip/vertebral fractures in middle aged and elderly patients. Methods This was …

Background: Angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor
blockers (ARBs) may be associated with higher susceptibility of COVID-19 infection and …